The Post-Menopausal Women Study

In postmenopausal women, the hormone follicle stimulating hormone (FSH) is high elevated, this is shown to quicken aging, and lead to decreased bone mass, reduced muscle mass and increased fat mass. It also increases the risk of diabetes, metabolic syndrome (increasing the risk of a stroke and diabetes), kidney dysfunction, heart diseases and Alzheimer’s disease.

The study drug is designed to block proteins in our bodies that stimulate FSH, by blocking these proteins that control the release of FSH hormones bone loss, muscle mass and fat mass may be reduced.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.